GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Additional Paid-In Capital

ENCell Co (XKRX:456070) Additional Paid-In Capital : ₩120,226 Mil(As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is ENCell Co Additional Paid-In Capital?


ENCell Co's quarterly additional paid-in capital increased from Sep. 2024 (₩119,679 Mil) to Dec. 2024 (₩120,120 Mil) and increased from Dec. 2024 (₩120,120 Mil) to Mar. 2025 (₩120,226 Mil).

ENCell Co's annual additional paid-in capital increased from Dec. 2022 (₩35,061 Mil) to Dec. 2023 (₩96,167 Mil) and increased from Dec. 2023 (₩96,167 Mil) to Dec. 2024 (₩120,120 Mil).

ENCell Co Additional Paid-In Capital Historical Data

The historical data trend for ENCell Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co Additional Paid-In Capital Chart

ENCell Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
5,775.30 10,858.27 35,060.98 96,166.85 120,119.67

ENCell Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only 96,166.85 96,166.85 119,678.80 120,119.67 120,226.25

ENCell Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

ENCell Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of ENCell Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

ENCell Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Additional Paid-In Capital
Comparable Companies
XKRX:251120 XKRX:214260 XKRX:338840 XKRX:299660 XKRX:376270 XKRX:048530 XKRX:311690 XKRX:278650 XKRX:084990 XKRX:321550 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR
Website
http://www.encellinc.com
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines